iStreet Network Other Announcement
iStreet Network Limited submitted its Annual Secretarial Compliance Report for FY26. The report notes compliance with SEBI regulations except for certain procedural delays and reclassification discrepancies.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
iStreet Network Limited submitted its Annual Secretarial Compliance Report for FY26. The report notes compliance with SEBI regulations except for certain procedural delays and reclassification discrepancies.
iStreet Network Limited disclosed related party transactions worth ₹29.94 Crore for the year ended March 31, 2026. The filing complies with SEBI Regulation 23(9) requirements.
iStreet Network Limited has relocated its registered office to the 4th floor of D J House in Mumbai. The administrative shift became effective from May 29, 2026.
iStreet Network Limited confirmed zero deviation in the utilization of ₹83.00 Crore raised via preferential issues. Funds were deployed for working capital and regional expansion.
iStreet Network redesignated Mr. Uttam Dave as Chairman and Managing Director for five years. The change, effective May 2026, aims to strengthen the company's executive leadership.
iStreet Network Ltd reported revenue from operations of ₹41.5 Cr (+591.7% YoY) and net profit of ₹0.4 Cr (+33.3% YoY) for Q4 FY26.
iStreet Network Ltd reported an annual total income of ₹99.86 Crore for FY26. Net profit stood at ₹4.96 Crore, reflecting significant year-on-year growth.
iStreet Network Limited announced management changes and office relocation during its board meeting. The company also approved audited financials for the year ended March 2026.
iStreet Network Limited received BSE listing approval for 18,33,334 equity shares following warrant conversions. This approval enables immediate trading of these newly issued securities.
iStreet Network scheduled a May 29 board meeting to approve fiscal 2026 results and leadership changes. Key items include MD resignation and potential redesignations.